First Time Loading...

Creo Medical Group PLC
LSE:CREO

Watchlist Manager
Creo Medical Group PLC Logo
Creo Medical Group PLC
LSE:CREO
Watchlist
Price: 35.875 GBX -0.35% Market Closed
Updated: Apr 30, 2024

Creo Medical Group PLC
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Creo Medical Group PLC
Revenue Peer Comparison

Comparables:
SN
LIVN
LMDX
EKF
AGL

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Creo Medical Group PLC
LSE:CREO
Revenue
£27.2m
CAGR 3-Years
1 163%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Smith & Nephew PLC
LSE:SN
Revenue
$5.5B
CAGR 3-Years
7%
CAGR 5-Years
3%
CAGR 10-Years
N/A
LivaNova PLC
NASDAQ:LIVN
Revenue
$1.2B
CAGR 3-Years
7%
CAGR 5-Years
1%
CAGR 10-Years
N/A
LumiraDx Ltd
NASDAQ:LMDX
Revenue
$254.5m
CAGR 3-Years
123%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
EKF Diagnostics Holdings PLC
LSE:EKF
Revenue
£52.6m
CAGR 3-Years
-7%
CAGR 5-Years
4%
CAGR 10-Years
5%
Angle PLC
LSE:AGL
Revenue
£1.8m
CAGR 3-Years
31%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Creo Medical Group PLC's Revenue?
Revenue
27.2m GBP

Based on the financial report for Dec 31, 2022, Creo Medical Group PLC's Revenue amounts to 27.2m GBP.

What is Creo Medical Group PLC's Revenue growth rate?
Revenue CAGR 3Y
1 163%

Over the last year, the Revenue growth was 8%. The average annual Revenue growth rates for Creo Medical Group PLC have been 1 163% over the past three years .